Found: 56
Select item for more details and to access through your institution.
NCI-sponsored trial for the evaluation of safety and preliminary efficacy of 3'-deoxy-3'-[18F]fluorothymidine (FLT) as a marker of proliferation in patients with recurrent gliomas: preliminary efficacy studies.
- Published in:
- 2009
- By:
- Publication type:
- journal article
NCI-sponsored trial for the evaluation of safety and preliminary efficacy of FLT as a marker of proliferation in patients with recurrent gliomas: safety studies.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Assessment of the Effects of Age, Gender, and Exercise Training on the Cardiac Sympathetic Nervous System Using Positron Emission Tomography Imaging.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The complex nature of research dissemination practices among public health faculty researchers.
- Published in:
- Journal of the Medical Library Association, 2019, v. 107, n. 3, p. 341, doi. 10.5195/jmla.2019.524
- By:
- Publication type:
- Article
[18F]-fluoromisonidazole (FMISO) PET/MRI hypoxic fraction distinguishes neuroinflammatory pseudoprogression from recurrent glioblastoma in patients treated with pembrolizumab.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 3, p. 246, doi. 10.1093/nop/npac021
- By:
- Publication type:
- Article
[<sup>11</sup>C]Metahydroxyephedrine and [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography Improve Clinical Decision Making in Suspected Pheochromocytoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2006, v. 13, n. 2, p. 187, doi. 10.1245/ASO.2006.04.022
- By:
- Publication type:
- Article
Activity of P-glycoprotein, an ABC efflux transporter at the blood-brain barrier, is compromised in Alzheimer's disease
- Published in:
- 2012
- By:
- Publication type:
- Abstract
<sup>18</sup>F-fluorodeoxyglucose (FDG) PET or <sup>18</sup>F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Reply.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 77, n. 6, p. 503, doi. 10.1016/j.clpt.2005.01.022
- By:
- Publication type:
- Article
Uterine Uptake of Estrogen and Progestogen-Based Radiotracers in Rhesus Macaques with Endometriosis.
- Published in:
- Molecular Imaging & Biology, 2024, v. 26, n. 2, p. 334, doi. 10.1007/s11307-023-01892-9
- By:
- Publication type:
- Article
In Vivo Cerebral Imaging of Mutant Huntingtin Aggregates Using <sup>11</sup>C-CHDI-180R PET in a Nonhuman Primate Model of Huntington Disease.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1581, doi. 10.2967/jnumed.123.265569
- By:
- Publication type:
- Article
<sup>18</sup>F-Fluoroestradiol (<sup>18</sup>F-FES)-PET imaging in a Phase II trial of vorinostat to restore endocrine sensitivity in ER+/HER2- metastatic breast cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.244459
- By:
- Publication type:
- Article
<sup>18</sup>F-Fluoroestradiol (18F-FES)-PET imaging in a Phase II trial of vorinostat to restore endocrine sensitivity in ER+/HER2- metastatic breast cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.244459
- By:
- Publication type:
- Article
<sup>18</sup>F-Fluoroestradiol (<sup>18</sup>F-FES)-PET imaging in a Phase II trial of vorinostat to restore endocrine sensitivity in ER+/HER2- metastatic breast cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.244459
- By:
- Publication type:
- Article
<sup>18</sup>F-Fluoroestradiol (<sup>18</sup>F-FES)-PET imaging in a Phase II trial of vorinostat to restore endocrine sensitivity in ER+/HER2- metastatic breast cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.244459
- By:
- Publication type:
- Article
<sup>18</sup>F-Fluoroestradiol (<sup>18</sup>F-FES)-PET imaging in a Phase II trial of vorinostat to restore endocrine sensitivity in ER+/HER2-metastatic breast cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.244459
- By:
- Publication type:
- Article
Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 7, p. 1106, doi. 10.2967/jnumed.113.130161
- By:
- Publication type:
- Article
Modeling Cyclosporine A Inhibition of the Distribution of a P-Glycoprotein PET Ligand, <sup>11</sup>C-Verapamil, into the Maternal Brain and Fetal Liver of the Pregnant Nonhuman Primate: Impact of Tissue Blood Flow and Site of Inhibition.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 3, p. 437, doi. 10.2967/jnumed.112.111732
- By:
- Publication type:
- Article
The Future of USP Monographs for PET Drugs.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 3, p. 472, doi. 10.2967/jnumed.112.115089
- By:
- Publication type:
- Article
Between-Patient and Within-Patient (Site-to-Site) Variability in Estrogen Receptor Binding, Measured In Vivo by <sup>18</sup>F-Fluoroestradiol PET.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 10, p. 1541, doi. 10.2967/jnumed.111.091439
- By:
- Publication type:
- Article
Multiagent PET for Risk Characterization in Sarcoma.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 4, p. 541, doi. 10.2967/jnumed.110.083717
- By:
- Publication type:
- Article
Imaging of Cyclosporine Inhibition of P-Glycoprotein Activity Using <sup>11</sup>C-Verapamil in the Brain: Studies of Healthy Humans.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 8, p. 1267, doi. 10.2967/jnumed.108.059162
- By:
- Publication type:
- Article
Simultaneous PET Imaging of P-Glycoprotein Inhibition in Multiple Tissues in the Pregnant Nonhuman Primate.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 5, p. 798, doi. 10.2967/jnumed.108.059360
- By:
- Publication type:
- Article
Reduced D<sub>2</sub>/D<sub>3</sub> Receptor Binding and Glucose Metabolism in a Macaque Model of Huntington's Disease.
- Published in:
- Movement Disorders, 2023, v. 38, n. 1, p. 143, doi. 10.1002/mds.29271
- By:
- Publication type:
- Article
Book Reviews.
- Published in:
- 1996
- By:
- Publication type:
- Book Review
Synthesis of tritiated diborane and cryptand [2.2.2].
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 1990, v. 28, n. 10, p. 1171, doi. 10.1002/jlcr.2580281009
- By:
- Publication type:
- Article
Kinetic Analysis of 2-[[sup11] C]Thymidine PET Imaging Studies of Malignant Brain Tumors: Preliminary Patient Results.
- Published in:
- Molecular Imaging, 2002, v. 1, n. 3, p. 145, doi. 10.1162/153535002760235445
- By:
- Publication type:
- Article
Correction to: a Phase 2 Study of 16α-[18F]-Fluoro-17β-Estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC).
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase 2 study of 16α-[18F]-fluoro-17β-estradiol positron emission tomography (FES-PET) as a marker of hormone sensitivity in metastatic breast cancer (MBC).
- Published in:
- 2014
- By:
- Publication type:
- journal article
A Phase 2 Study of 16α-[F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC).
- Published in:
- Molecular Imaging & Biology, 2014, v. 16, n. 3, p. 431, doi. 10.1007/s11307-013-0699-7
- By:
- Publication type:
- Article
Molecular Imaging of Hypoxia.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 6, p. 129S, doi. 10.2967/jnumed.107.045914
- By:
- Publication type:
- Article
Tumor Receptor Imaging.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 6, p. 149S, doi. 10.2967/jnumed.107.045963
- By:
- Publication type:
- Article
Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and <sup>18</sup>F-Fluoroestradiol.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 3, p. 367, doi. 10.2967/jnumed.107.047506
- By:
- Publication type:
- Article
Evidence for Pre- to Postsynaptic Mismatch of the Cardiac Sympathetic Nervous System in Ischemic Congestive Heart Failure.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 2, p. 234, doi. 10.2967/jnumed.107.044339
- By:
- Publication type:
- Article
Kinetic Analysis of 3'-Deoxy-3'-<sup>18</sup>F- Fluorothymidine in Patients with Gliomas.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 10, p. 1612
- By:
- Publication type:
- Article
Evaluation of <sup>18</sup>F-Annexin V as a PET Imaging Agent in an Animal Model of Apoptosis.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 4, p. 658
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG Kinetics in Locally Advanced Breast Cancer: Correlation with Tumor Blood Flow and Changes in Response to Neoadjuvant Chemotherapy.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 11, p. 1829
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET of Gliomas at Delayed Intervals: Improved Distinction Between Tumor and Normal Gray Matter.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 10, p. 1653
- By:
- Publication type:
- Article
Comparison of Different Quantitative Approaches to <sup>18</sup>F-Fluoride PET Scans.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 9, p. 1493
- By:
- Publication type:
- Article
The FDG Lumped Constant in Normal Human Brain.
- Published in:
- Journal of Nuclear Medicine, 2002, v. 43, n. 9, p. 1157
- By:
- Publication type:
- Article
[<sup>18</sup>F]Fluoroestradiol Radiation Dosimetry in Human PET Studies.
- Published in:
- Journal of Nuclear Medicine, 2001, v. 42, n. 4, p. 679
- By:
- Publication type:
- Article
Kinetic Analysis of 2-[<sup>11</sup>C]Thymidine PET Imaging Studies: Validation Studies.
- Published in:
- Journal of Nuclear Medicine, 1999, v. 40, n. 4, p. 614
- By:
- Publication type:
- Article
1-[Carbon-11]-Glucose RadiationDosimetry and Distribution in Human Imaging Studies.
- Published in:
- Journal of Nuclear Medicine, 1998, v. 39, n. 10, p. 1805
- By:
- Publication type:
- Article
Carbon- 11-Thymidine and FDG to Measure Therapy Response.
- Published in:
- Journal of Nuclear Medicine, 1998, v. 39, n. 10, p. 1757
- By:
- Publication type:
- Article
Quantitation of Presynaptic Cardiac Sympathetic Function with Carbon-11-Meta-Hydroxyephedrine.
- Published in:
- Journal of Nuclear Medicine, 1998, v. 39, n. 8, p. 1327
- By:
- Publication type:
- Article
Kinetic Analysis of 2-[Carbon-11] Thymidine PET Imaging Studies: Compartmental Model and Mathematical Analysis.
- Published in:
- Journal of Nuclear Medicine, 1998, v. 39, n. 6, p. 1043
- By:
- Publication type:
- Article
Glucose Metabolism in Human Malignant Gliomas Measured Quantitatively with PET, 1-[C-11]Glucose and FDG: Analysis of the FDG Lumped Constant.
- Published in:
- Journal of Nuclear Medicine, 1998, v. 39, n. 3, p. 440
- By:
- Publication type:
- Article
Fluorine-18-Fluoromisonidazole Radiation Dosimetry in Imaging Studies.
- Published in:
- Journal of Nuclear Medicine, 1997, v. 38, n. 10, p. 1631
- By:
- Publication type:
- Article
Feasibility of Imaging Pentose Cycle Glucose Metabolism in Gliomas with PET: Studies in Rat Brain Tumor Models.
- Published in:
- Journal of Nuclear Medicine, 1997, v. 38, n. 4, p. 617
- By:
- Publication type:
- Article